Overview

A Study on the Efficacy and Gut Microbiota of Berberine and Probiotics in Patients With Newly Diagnosed Type 2 Diabetes

Status:
Unknown status

Trial end date:
2019-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to conduct a multicenter randomized, double-blind, placebo-controlled clinical trial, evaluating the effects and change of gut microbiota after berberine and/or probiotics administration in patients with newly diagnosed type 2 diabetes

Phase:

Phase 3

Details

Lead Sponsor:

Shanghai Jiao Tong University School of Medicine

Treatments:

Diphenhydramine
Promethazine